Latest News

Recent findings show that approximately 61% of sexually active older women in their 60s through to their 80s were happy with their sex lives and this was also the case for those who did not have a partner or who were not at that time sexually active...

Libigel late stage trials proved disappointing when it did not meet its primary or secondary endpoints relating to an increase in satisfaction and desire in postmenopausal women...

Apricus Biosciences is finally ready to market their erectile dysfunction treatment, Vitaros this November in Canada...

Biosante Pharmacueticals, who are running phase III trials for the latest hopeful in HSDD (hypoactive sexual desire disorder), Libigel ( testosterone gel) have now completed the recruitment part of their trial and now may commence the study which will observe the safety and efficacy of this treatmen...

On and on goes the debate about whether or not Hypoactive Sexual Desire Disorder (HSDD) can be addressed as a physiological disorder...